{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T00:24:01Z","timestamp":1760401441947,"version":"build-2065373602"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T00:00:00Z","timestamp":1760313600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T00:00:00Z","timestamp":1760313600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100009139","name":"German Center for Infection Research","doi-asserted-by":"crossref","award":["TTU 03.708"],"award-info":[{"award-number":["TTU 03.708"]}],"id":[{"id":"10.13039\/100009139","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Open Access funding enabled and organized by Projekt DEAL"},{"name":"Bernhard-Nocht-Institut f\u00fcr Tropenmedizin"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Malar J"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Recurrent events of infectious diseases are common and the subject of analyses in many clinical studies. A proper understanding of disease occurrence over time within a cohort provides a basis for study planning and sample size estimation. This study mathematically describes the recurrence of malaria in a malaria-na\u00efve cohort and highlights the necessary assumptions to inform study planning.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>To represent different disease transmission scenarios, five mathematical models with different levels of complexity were constructed to mimic possible real-life scenarios. Model A represents the simplest model with constant infection risk, Model B includes protection due to treatment and reduced individual susceptibility after each infection, Model C shows preventive effects from a vaccination, Model D explores heterogeneous transmission with varying levels of infection risks, and Model E captures temporal dynamics through seasonal variation in infection risk. The models were implemented as compartmental models using a system of ordinary differential equations.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>The different transmission scenarios strongly affected the pattern of recurrent infections. Models A and B had the same number of cases with infections; however, due to treatment effects and immunity development, the number of recurrent events was lower in Model B. Compared to Model B, Model C showed a substantial reduction in both first and recurring infections. In Model D, the subpopulation with a high transmission risk had a higher proportion of recurrent infections, with nearly 100% of this group experiencing more than one infection. Model E demonstrated how seasonal transmission risk leads to temporal dynamics with strong fluctuations in the occurrence of infections. Based on these models, we provide examples of how final cohort sizes can be estimated for different transmission settings.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>Recurrent infections in longitudinal studies cannot be estimated directly from disease frequency data. However, this study provides a simple set of equations to calculate the number of expected recurrent events. These models can be easily adapted to represent additional transmission and infection dynamics or to model other recurrent diseases like influenza.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s12936-025-05594-1","type":"journal-article","created":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T08:18:06Z","timestamp":1760343486000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["How do recurrent malaria infections occur in clinical cohorts: a mathematical modelling study to support study planning"],"prefix":"10.1186","volume":"24","author":[{"given":"Ralf","family":"Krumkamp","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lydia Helen","family":"Rautman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oumou","family":"Maiga-Ascofar\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00fcrgen","family":"May","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eva","family":"Lorenz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,10,13]]},"reference":[{"key":"5594_CR1","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1038\/sj.bjc.6601118","volume":"89","author":"TG Clark","year":"2003","unstructured":"Clark TG, Bradburn MJ, Love SB, Altman DG. Survival analysis. Part I: basic concepts and first analyses. Br J Cancer. 2003;89:232\u20138.","journal-title":"Br J Cancer"},{"key":"5594_CR2","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1111\/j.1365-3024.2009.01144.x","volume":"31","author":"WP O\u2019Meara","year":"2009","unstructured":"O\u2019Meara WP, Lang T. Malaria vaccine trial endpoints\u2013bridging the gaps between trial design, public health and the next generation of vaccines. Parasite Immunol. 2009;31:574\u201381.","journal-title":"Parasite Immunol"},{"key":"5594_CR3","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/S0140-6736(23)02511-4","volume":"403","author":"MS Datoo","year":"2024","unstructured":"Datoo MS, Dicko A, Tinto H, Ou\u00e9draogo J-B, Hamaluba M, Olotu A, et al. Safety and efficacy of malaria vaccine candidate R21\/Matrix-M in African children: a multicentre, double-blind, randomised, phase 3 trial. Lancet. 2024;403:533\u201344.","journal-title":"Lancet"},{"key":"5594_CR4","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1093\/ije\/dyu222","volume":"44","author":"LD Amorim","year":"2015","unstructured":"Amorim LD, Cai J. Modelling recurrent events: a tutorial for analysis in epidemiology. Int J Epidemiol. 2015;44:324\u201333.","journal-title":"Int J Epidemiol"},{"key":"5594_CR5","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1111\/j.1541-0420.2007.00948.x","volume":"64","author":"R Song","year":"2008","unstructured":"Song R, Kosorok MR, Cai J. Robust covariate-adjusted log-rank statistics and corresponding sample size formula for recurrent events data. Biometrics. 2008;64:741\u201350.","journal-title":"Biometrics"},{"key":"5594_CR6","doi-asserted-by":"publisher","first-page":"4819","DOI":"10.1002\/sim.8335","volume":"38","author":"Y Tang","year":"2019","unstructured":"Tang Y, Fitzpatrick R. Sample size calculation for the Andersen-gill model comparing rates of recurrent events. Stat Med. 2019;38:4819\u201327.","journal-title":"Stat Med"},{"key":"5594_CR7","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1002\/pst.2154","volume":"21","author":"L Zhu","year":"2022","unstructured":"Zhu L, Li Y, Tang Y, Shen L, Onar-Thomas A, Sun J. Sample size calculation for recurrent event data with additive rates models. Pharm Stat. 2022;21:89\u2013102.","journal-title":"Pharm Stat"},{"key":"5594_CR8","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s12874-015-0005-2","volume":"15","author":"A Jahn-Eimermacher","year":"2015","unstructured":"Jahn-Eimermacher A, Ingel K, Ozga A-K, Preussler S, Binder H. Simulating recurrent event data with hazard functions defined on a total time scale. BMC Med Res Methodol. 2015;15:16.","journal-title":"BMC Med Res Methodol"},{"key":"5594_CR9","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1002\/sim.693","volume":"20","author":"MVP Bernardo","year":"2001","unstructured":"Bernardo MVP, Harrington DP. Sample size calculations for the two-sample problem using the multiplicative intensity model. Stat Med. 2001;20:557\u201379.","journal-title":"Stat Med"},{"key":"5594_CR10","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1021\/js970414z","volume":"87","author":"Y Sun","year":"1998","unstructured":"Sun Y, Jusko WJ. Transit compartments versus gamma distribution function to model signal transduction processes in pharmacodynamics. J Pharm Sci. 1998;87:732\u20137.","journal-title":"J Pharm Sci"},{"key":"5594_CR11","doi-asserted-by":"publisher","DOI":"10.1093\/oso\/9780190665760.001.0001","volume-title":"Epidemiology by design","author":"D Westreich","year":"2019","unstructured":"Westreich D. Epidemiology by design. New York: Oxford University Press; 2019."},{"key":"5594_CR12","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1136\/bmj.312.7027.364","volume":"312","author":"RJ Glynn","year":"1996","unstructured":"Glynn RJ, Buring JE. Ways of measuring rates of recurrent events. BMJ. 1996;312:364\u20137.","journal-title":"BMJ"},{"key":"5594_CR13","doi-asserted-by":"crossref","unstructured":"Halloran ME, Longini IM, Struchiner CJ. Binomial and stochastic transmission models. In: Halloran ME, Longini IM, Struchiner CJ editors. Design and analysis of vaccine studies. Springer; 2010.","DOI":"10.1007\/978-0-387-68636-3"},{"key":"5594_CR14","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s12916-020-1494-3","volume":"18","author":"MT Bretscher","year":"2020","unstructured":"Bretscher MT, Dahal P, Griffin J, Stepniewska K, Bassat Q, Baudin E, et al. The duration of chemoprophylaxis against malaria after treatment with artesunate-amodiaquine and artemether-lumefantrine and the effects of pfmdr1 86Y and pfcrt 76T: a meta-analysis of individual patient data. BMC Med. 2020;18:47.","journal-title":"BMC Med"},{"key":"5594_CR15","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1038\/ni.f.205","volume":"9","author":"J Langhorne","year":"2008","unstructured":"Langhorne J, Ndungu FM, Sponaas A-M, Marsh K. Immunity to malaria: more questions than answers. Nat Immunol. 2008;9:725\u201332.","journal-title":"Nat Immunol"},{"key":"5594_CR16","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1128\/CMR.00025-08","volume":"22","author":"DL Doolan","year":"2009","unstructured":"Doolan DL, Doba\u00f1o C, Baird JK. Acquired immunity to malaria. Clin Microbiol Rev. 2009;22:13\u201336.","journal-title":"Clin Microbiol Rev"},{"key":"5594_CR17","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1093\/infdis\/jiz510","volume":"221","author":"M Eldh","year":"2020","unstructured":"Eldh M, Hammar U, Arnot D, Beck H-P, Garcia A, Liljander A, et al. Multiplicity of asymptomatic Plasmodium falciparum infections and risk of clinical malaria: a systematic review and pooled analysis of individual participant data. J Infect Dis. 2020;221:775\u201385.","journal-title":"J Infect Dis"},{"key":"5594_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/S2666-5247(21)00180-4","volume":"2","author":"MM Patel","year":"2021","unstructured":"Patel MM, York IA, Monto AS, Thompson MG, Fry AM. Immune-mediated attenuation of influenza illness after infection: opportunities and challenges. Lancet Microbe. 2021;2:e715\u201325.","journal-title":"Lancet Microbe"},{"key":"5594_CR19","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1038\/6560","volume":"5","author":"S Gupta","year":"1999","unstructured":"Gupta S, Snow RW, Donnelly CA, Marsh K, Newbold C. Immunity to non-cerebral severe malaria is acquired after one or two infections. Nat Med. 1999;5:340\u20133.","journal-title":"Nat Med"},{"key":"5594_CR20","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1017\/S0031182015001249","volume":"143","author":"FJI Fowkes","year":"2016","unstructured":"Fowkes FJI, Boeuf P, Beeson JG. Immunity to malaria in an era of declining malaria transmission. Parasitology. 2016;143:139\u201353.","journal-title":"Parasitology"},{"key":"5594_CR21","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.4269\/ajtmh.21-0788","volume":"106","author":"B Fofana","year":"2022","unstructured":"Fofana B, Takala-Harrison S, Ouattara A, Sagara I, Togo AH, Diakit\u00e9 H, et al. Differential incidence of malaria in neighboring villages in a high-transmission setting of southern Mali. Am J Trop Med Hyg. 2022;106:1209\u201314.","journal-title":"Am J Trop Med Hyg"},{"key":"5594_CR22","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.1007\/s10708-022-10692-7","volume":"88","author":"AA Millogo","year":"2022","unstructured":"Millogo AA, Yam\u00e9ogo L, Kassi\u00e9 D, de Charles Ou\u00e9draogo F, Guissou C, Diabat\u00e9 A. Spatial modelling of malaria prevalence associated with geographical factors in Houet province of Burkina Faso, West Africa. GeoJournal. 2022;88:1769\u201383.","journal-title":"GeoJournal"},{"key":"5594_CR23","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1186\/s12916-015-0354-z","volume":"13","author":"J Rono","year":"2015","unstructured":"Rono J, F\u00e4rnert A, Murungi L, Ojal J, Kamuyu G, Guleid F, et al. Multiple clinical episodes of Plasmodium falciparum malaria in a low transmission intensity setting: exposure versus immunity. BMC Med. 2015;13:114.","journal-title":"BMC Med"},{"key":"5594_CR24","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1186\/s12936-019-2763-5","volume":"18","author":"S Lawpoolsri","year":"2019","unstructured":"Lawpoolsri S, Sattabongkot J, Sirichaisinthop J, Cui L, Kiattibutr K, Rachaphaew N, et al. Epidemiological profiles of recurrent malaria episodes in an endemic area along the Thailand-Myanmar border: a prospective cohort study. Malar J. 2019;18:124.","journal-title":"Malar J"},{"key":"5594_CR25","first-page":"128","volume":"2","author":"LJS Allen","year":"2017","unstructured":"Allen LJS. A primer on stochastic epidemic models: formulation, numerical simulation, and analysis. Infect Dis Model. 2017;2:128\u201342.","journal-title":"Infect Dis Model"}],"container-title":["Malaria Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12936-025-05594-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12936-025-05594-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12936-025-05594-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T08:18:07Z","timestamp":1760343487000},"score":1,"resource":{"primary":{"URL":"https:\/\/malariajournal.biomedcentral.com\/articles\/10.1186\/s12936-025-05594-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,13]]},"references-count":25,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["5594"],"URL":"https:\/\/doi.org\/10.1186\/s12936-025-05594-1","relation":{},"ISSN":["1475-2875"],"issn-type":[{"value":"1475-2875","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,13]]},"assertion":[{"value":"16 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"329"}}